References
- D’AmatoGSteinertDMMcAuliffeJCTrentJCUpdate on the biology and therapy of gastrointestinal stromal tumorsCancer Control2005121445615668652
- GoldJSDeMatteoRPCombined surgical and molecular therapy: the gastrointestinal stromal tumor modelAnn Surg2006244217618416858179
- Van der ZwanSMDeMatteoRPGastrointestinal stromal tumor: 5 years laterCancer200510491781178816136600
- DemetriGDIdentification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)Eur J Cancer200238Suppl 5S52S5912528773
- NCCN.org [homepage on the Internet]The NCCN Clinical Practice Guidelines in Oncology™ Soft Tissue Carcinoma (Version I.2009) ©2009 National Comprehensive Cancer Network, Inc. Available from: http://www.NCCN.org. Accessed May 5, 2009.
- NgEHPollockREMunsellMFAtkinsonENRomsdahlMMPrognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and stagingAnn Surg1992215168771731651
- DeMatteoRPLewisJJLeungDMudanSSWoodruffJMBrennanMFTwo hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survivalAnn Surg20002311515810636102
- ShiuMHFarrGHPapachristouDNHajduSIMyosarcomas of the stomach: natural history, prognostic factors and managementCancer19824911771877053814
- DeMatteoRPGoldJSSaranLTumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)Cancer2008112360861518076015
- NilssonBBummingPMeis-KindblomJMGastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western SwedenCancer2005103482182915648083
- MiettinenMLasotaJGastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosisArch Pathol Lab Med2006130101466147817090188
- TranTDavilaJAEl-SeragHBThe epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000Am J Gastroenterol2005100116216815654796
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
- LinDYFeuerEJEtzioniRWaxYEstimating medical costs from incomplete follow-up dataBiometrics19975324194349192444
- MartinJPovedaALlombart-BoschASpanish Group for Sarcoma Research. Deletions affecting codons 557–558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)J Clin Oncol200523256190619816135486
- StokesMThompsonDMontoyaEWeinsteinMCWinerEPEarleCCTen-year survival and cost following breast cancer recurrence: estimates from SEER-medicare dataValue Health200811221322018380633
- HoweJRKarnellLHScott-ConnerCSmall bowel sarcoma: analysis of survival from the National Cancer Data BaseAnn Surg Oncol20018649650811456049
- FreyCMMcMillenMMCowanCDHormJWKesslerLGRepresentativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality ratesJ Natl Cancer Inst199284118728771593655